Verastem Oncology
About Verastem Oncology
Verastem Oncology, a biopharmaceutical innovator, is dedicated to pioneering novel small-molecule therapies targeting the RAS/MAPK signaling pathway for aggressive cancers. They focus on combination treatments, including RAF/MEK clamp and FAK inhibitors, holding an FDA-approved combination for KRAS-mutant ovarian cancer. Verastem strategically advances its pipeline through clinical trials and collaborations, aiming to revolutionize cancer treatment by targeting RAS-driven tumor biology.
Current Openings
1 Job Opening Found at Verastem Oncology
Oncology Account Manager
Oncology Account Manager
Verastem Oncology
Drive the launch of Avutometinib and Defactinib at Verastem Oncology. Build relationships, educate stakeholders, and achieve business goals in oncology accounts.